×
Co-Diagnostics EBIT Margin 2017-2025 | CODX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Co-Diagnostics ebit margin from 2017 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
View More
Co-Diagnostics EBIT Margin 2017-2025 | CODX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Co-Diagnostics ebit margin from 2017 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$147.3B
CVS Health (CVS)
$83.1B
Elevance Health (ELV)
$65.9B
Cencora (COR)
$56B
DiDi Global (DIDIY)
$26.7B
Labcorp Holdings (LH)
$22.4B
Natera (NTRA)
$21.9B
BioMerieux (BMXMF)
$17.2B
EUROFINS SCIENT (ERFSF)
$15.3B
ICON (ICLR)
$13.7B
CochLear (CHEOY)
$13.3B
Medpace Holdings (MEDP)
$12.9B
Solventum (SOLV)
$12.5B
Viatris (VTRS)
$11.8B
Revvity (RVTY)
$10.2B
Sonic Healthcare (SKHHY)
$9.2B
Avantor (AVTR)
$8.6B
Caris Life Sciences,�Inc (CAI)
$8.3B
HealthEquity (HQY)
$8B
Charles River Laboratories (CRL)
$7.5B
Bausch + Lomb (BLCO)
$4.9B
Sotera Health (SHC)
$4.2B
Amplifon S.p.A (AMFPF)
$3.9B
BrightSpring Health Services (BTSG)
$3.8B
GeneDx Holdings (WGS)
$3.3B
Surgery Partners (SGRY)
$2.9B
Alignment Healthcare (ALHC)
$2.9B
Concentras Parent (CON)
$2.9B
Organon (OGN)
$2.4B
Premier (PINC)
$2B